ICSC 0116 - CADMIUM CHLORIDE

« back to the search result list

CADMIUM CHLORIDE	ICSC: 0116 (April 2005)
Cadmium dichloride

CAS #: 10108-64-2

UN #: 2570

EC Number: 233-296-7

	ACUTE HAZARDS	PREVENTION	FIRE FIGHTING
FIRE & EXPLOSION	Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.		In case of fire in the surroundings, use appropriate extinguishing media.

PREVENT DISPERSION OF DUST! AVOID ALL CONTACT! IN ALL CASES CONSULT A DOCTOR!
	SYMPTOMS	PREVENTION	FIRST AID
Inhalation	Cough. Laboured breathing. Symptoms may be delayed. See Notes.	Use closed system or ventilation.	Fresh air, rest. Half-upright position. Artificial respiration may be needed. Refer for medical attention.
Skin	Redness.	Protective gloves. Protective clothing.	Remove contaminated clothes. Rinse skin with plenty of water or shower.
Eyes	Redness. Pain.	Wear safety goggles or eye protection in combination with breathing protection if powder.	First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.
Ingestion	Abdominal pain. Burning sensation. Diarrhoea. Nausea. Vomiting.	Do not eat, drink, or smoke during work. Wash hands before eating.	Rinse mouth. Give one or two glasses of water to drink. Refer for medical attention .

SPILLAGE DISPOSAL	CLASSIFICATION & LABELLING
Personal protection: chemical protection suit including self-contained breathing apparatus. Do NOT let this chemical enter the environment. Sweep spilled substance into covered sealable containers. If appropriate, moisten first to prevent dusting. Carefully collect remainder. Then store and dispose of according to local regulations.	According to UN GHS Criteria Transportation UN Classification UN Hazard Class: 6.1; UN Pack Group: III
STORAGE
Store in an area without drain or sewer access. Separated from strong oxidants and food and feedstuffs. Dry. Well closed.
PACKAGING
Unbreakable packaging. Put breakable packaging into closed unbreakable container. Do not transport with food and feedstuffs. Severe marine pollutant.

CADMIUM CHLORIDE

ICSC: 0116

PHYSICAL & CHEMICAL INFORMATION
Physical State; Appearance ODOURLESS COLOURLESS HYGROSCOPIC CRYSTALS. Physical dangers Chemical dangers Decomposes on heating. This produces very toxic fumes of cadmium and chlorine. Reacts with strong oxidants. This produces toxic fumes of chlorine.	Formula: CdCl₂ Molecular mass: 183.3 Boiling point: 960°C Melting point: 568°C Density: 4.1 g/cm³ Solubility in water: good

PHYSICAL & CHEMICAL INFORMATION

Physical State; Appearance
ODOURLESS COLOURLESS HYGROSCOPIC CRYSTALS.

Physical dangers

Chemical dangers
Decomposes on heating. This produces very toxic fumes of cadmium and chlorine. Reacts with strong oxidants. This produces toxic fumes of chlorine.

Formula: CdCl₂
Molecular mass: 183.3
Boiling point: 960°C
Melting point: 568°C
Density: 4.1 g/cm³
Solubility in water: good

EXPOSURE & HEALTH EFFECTS
Routes of exposure The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. Effects of short-term exposure The substance is severely irritating to the eyes, skin and respiratory tract. The substance is severely irritating to the gastrointestinal tract. Inhalation of the aerosol may cause lung oedema. See Notes. Exposure far above the OEL could cause death. The effects may be delayed. Medical observation is indicated.	Inhalation risk A harmful concentration of airborne particles can be reached quickly when dispersed, especially if powdered. Effects of long-term or repeated exposure The substance may have effects on the kidneys and lungs. This may result in kidney impairment and tissue lesions. This substance is carcinogenic to humans.

EXPOSURE & HEALTH EFFECTS

Routes of exposure
The substance can be absorbed into the body by inhalation of its aerosol and by ingestion.

Effects of short-term exposure
The substance is severely irritating to the eyes, skin and respiratory tract. The substance is severely irritating to the gastrointestinal tract. Inhalation of the aerosol may cause lung oedema. See Notes. Exposure far above the OEL could cause death. The effects may be delayed. Medical observation is indicated.

Inhalation risk
A harmful concentration of airborne particles can be reached quickly when dispersed, especially if powdered.

Effects of long-term or repeated exposure
The substance may have effects on the kidneys and lungs. This may result in kidney impairment and tissue lesions. This substance is carcinogenic to humans.

OCCUPATIONAL EXPOSURE LIMITS
TLV: (respirable fraction): 0.002 mg/m³, as TWA; 0.01 mg/m³, as TWA; A2 (suspected human carcinogen); BEI issued. MAK: (as Cd, inhalable fraction): skin absorption (H); carcinogen category: 1; germ cell mutagen group: 3A. EU-OEL: (inhalable fraction): 0.001 mg/m³ as TWA; (see Notes)

ENVIRONMENT
The substance is toxic to aquatic organisms. Bioaccumulation of this chemical may occur in plants. It is strongly advised not to let the chemical enter into the environment.

NOTES
Depending on the degree of exposure, periodic medical examination is suggested. Do NOT take working clothes home. The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential. Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered. An EU-OEL of 0.004 mg/m³ is allowed until 11 July 2027.

NOTES

Depending on the degree of exposure, periodic medical examination is suggested.
Do NOT take working clothes home.
The symptoms of lung oedema often do not become manifest until a few hours have passed and they are aggravated by physical effort.
Rest and medical observation are therefore essential.
Immediate administration of an appropriate inhalation therapy by a doctor, or by an authorized person, should be considered.
An EU-OEL of 0.004 mg/m³ is allowed until 11 July 2027.

ADDITIONAL INFORMATION

EC Classification
Symbol: T+, N; R: 45-46-60-61-25-26-48/23/25-50/53; S: 53-45-60-61; Note: E

All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.